HIGHLIGHTS
- who: Zibi Marchocki from the Department of Surgical Oncology, Division of Gynecologic Oncology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada have published the Article: Impact of neoadjuvant chemotherapy on somatic mutation status in high-grade serous ovarian carcinoma, in the Journal: (JOURNAL)
- what: The aim of this study is to determine the impact of NACT on somatic mutation status in platinum-sensitive and resistant HGSC.
- future: Future studies should focus on further exploration of site-specific post-NACT changes in comparison to malignant ascites and/or plasma samples in platinum . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.